Mahamaya Lifesciences fundamental analysis

MAHALIFE

180

5.00 (-2.70%)
Last updated on 16 Jan, 2026 | 15:19 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Mahamaya Lifesciences Fundamentals

P/E Ratio

32.55

P/B Ratio

3.71

Div. Yield

0

Sector P/E

39.59

Sector P/B

2.28

Sec. Div. Yield

0.35

Mahamaya Lifesciences Fundamentals is currently trading with a P/E Ratio of 32.55, compared to the sector average of 39.59. Its P/B Ratio stands at 3.71, while the sector’s is 2.28. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.35%.

Mahamaya Lifesciences Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Good

On its scorecard, Mahamaya Lifesciences reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.